Latest Breaking News On - Donor derived cell free - Page 1 : comparemela.com

AI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant Congress

AI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant Congress
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesFrance generalGaurav guptaJohnw hannaSean pinneyAlexandre loupyKiran khushDarshana dadhaniaAmerican transplant congressParis transplant groupCaredx incVirginia commonwealth universityTransplant companyTransplant congressCaredx presidentAllosure kidney

Natera Announces Publication of Largest Prospective dd-cfDNA Study in Kidney Transplantation

AUSTIN, Texas, April 11, 2024 Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced a new publication from the ProActive study in Transplantation supporting the use of the Prospera Kidney donor-derived cfDNA (dd-cfDNA) test as a leading indicator of kidney transplant rejection. The published manuscript can be found here.

United statesSan carlosJonathan brombergSamaniego picota milagrosSangeeta bhoradeNatera incClinical laboratory improvement amendmentsUniversity of maryland school medicineDrug administrationProspera kidneyMaryland schoolKidney transplant injuryDonor derived cell freeMassively multiplexDetect kidney allograftBiopsy proven rejection

CareDx s AlloSure Lung dd-cfDNA Testing Service Receives Medicare Coverage for Lung Transplant Rejection Monitoring

AlloSure Lung Represents First dd-cfDNA Approved by Medicare for Lung Transplant Patients

United statesCaredx allosureNirmal sharmaAppl labLung transplantation program at brighamTransplantation networkJ appl labCaredx incTransplant companyAllosure lungMedicare local coverage determinationMolecular testingSolid organ allograft rejectionGreg seetoSure lungMedical director

Independent Prospective Study Defines Reference Range for CareDx s AlloSure for Long-Term Lung Transplant Surveillance

Independent Prospective Study Defines Reference Range for CareDx s AlloSure for Long-Term Lung Transplant Surveillance
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCian cooneyAnna czeneVanderbilt university medical centerAppl labJ appl labLung transplant at vanderbilt university medical centerCaredx incDepartment of medicineVanderbilt university medical center the studyEstablish allosure lungBeyond two years post transplantEvaluating clinically stableTransplant companyTransplantation directGreg seeto

Natera Announces Publication Highlighting Importance of Testing Total cfDNA when Monitoring Kidney Transplant Patients with COVID-19 Infection

/PRNewswire/ Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, announced the results of a study1 to examine both total and.

United statesSan carlosMike brophyKate stabrawaNatera incClinical laboratory improvement amendmentsPrnewswire natera incDrug administrationPaulo school of medicineTransplantation proceedingsPaulo schoolKidney transplant patientsDonor derived cell freeDetect kidney allograftHigh cell freeRenal allograft patient with